Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PN400 vs Diclofenac/Misoprostol for Gastric Ulcer Prevention
NCT00594854Phase 3Terminated
- Sponsor
- Pozen
- Start
- Sep 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naproxen + esomeprazole in gastric ulcer (2 arms), sponsored by Pozen. Primary endpoint: Number of Participants With Gastric Ulcer Confirmed by Endoscopy at 6 months. Started Sep 2007; status: terminated.
02
Drugs
naproxen + esomeprazole
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on NCT00594854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594854.